AI-Assisted Endoscopy for Upper Aerodigestive Tract Lesions
- Sponsor
- Istituto Italiano di Tecnologia
- Study ID
- NCT07596355
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Head and Neck Cancer (H&N)
- Leukoplakia
- Squamous Cell Carcinoma
- Upper Aero-digestive Tract (UADT) Neoplasm
- Upper Aerodigestive Tract Neoplasms
- Upper AerodigestiveTract Cancer
- Vocal Cord Disease
- Vocal Fold Nodules
- Vocal Fold Polyp
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Study Details
This is a prospective observational clinical study designed to evaluate the performance of artificial intelligence (AI) algorithms applied to upper aerodigestive tract (UADT) video-endoscopy. The study assesses three main tasks: lesion detection (localization), classification (benign vs malignant), and segmentation of tumor margins. AI algorithms will be applied to endoscopic video data acquired during routine clinical practice without influencing clinical decision-making. The system will process images in real time and store data for subsequent analysis. AI outputs will be compared with physician assessment and reference standard histopathology to evaluate diagnostic performance.
Key Dates
- First listed
- May 19, 2026
- Start date
- May 31, 2026
- Status verified
- May 2026
- Primary completion
- Dec 31, 2027
- Completion
- Feb 29, 2028
Study Design
- Enrollment
- 283 participants (estimated)
Primary Outcome Measure
Negative Predictive Value of the CADx Algorithm for Malignant or Premalignant Upper Aerodigestive Tract Lesions [ Time Frame: From index outpatient UADT video-endoscopy until definitive histopathology result is available, assessed up to 60 days after endoscopy. ]
Central Contacts
- Leonardo De Mattos, PhD+39 010 2898 270
Find similar trials
Related Studies
- Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction DesignPHASE2 · Recruiting · Christopher Wilke · Pittsburgh, Pennsylvania
- T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung CancerPHASE2 · Recruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Pembrolizumab in Treating Participants With LeukoplakiaPHASE2 · Recruiting · Jonsson Comprehensive Cancer Center · La Jolla, California
- Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and NeckPHASE2 · Recruiting · Alain Algazi · San Francisco, California